These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10428706)

  • 1. An immunization against Alzheimer's?
    Barinaga M
    Science; 1999 Jul; 285(5425):175, 177. PubMed ID: 10428706
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization.
    Frenkel D; Dewachter I; Van Leuven F; Solomon B
    Vaccine; 2003 Mar; 21(11-12):1060-5. PubMed ID: 12559780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-peptide immunization: a possible new treatment for Alzheimer disease.
    Schenk DB; Seubert P; Lieberburg I; Wallace J
    Arch Neurol; 2000 Jul; 57(7):934-6. PubMed ID: 10891974
    [No Abstract]   [Full Text] [Related]  

  • 4. Is an effective immune intervention for Alzheimer's disease in prospect?
    Esiri MM
    Trends Pharmacol Sci; 2001 Jan; 22(1):2-3. PubMed ID: 11165659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active immunization of mice with an Abeta-Hsp70 vaccine.
    Koller MF; Mohajeri MH; Huber M; Wollmer MA; Roth Z'graggen BV; Sandmeier E; Moritz E; Tracy J; Nitsch RM; Christen P
    Neurodegener Dis; 2004; 1(1):20-8. PubMed ID: 16908970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards Alzheimer's disease vaccination.
    Solomon B
    Mini Rev Med Chem; 2002 Feb; 2(1):85-92. PubMed ID: 12369959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.
    Hock C; Konietzko U; Streffer JR; Tracy J; Signorell A; Müller-Tillmanns B; Lemke U; Henke K; Moritz E; Garcia E; Wollmer MA; Umbricht D; de Quervain DJ; Hofmann M; Maddalena A; Papassotiropoulos A; Nitsch RM
    Neuron; 2003 May; 38(4):547-54. PubMed ID: 12765607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current state of immunotherapy for Alzheimer's disease.
    Relkin NR
    CNS Spectr; 2008 Oct; 13(10 Suppl 16):39-41. PubMed ID: 18955962
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunization for Alzheimer's disease: yet closer to clinical trials.
    Gurwitz D
    Trends Mol Med; 2001 Sep; 7(9):385. PubMed ID: 11530319
    [No Abstract]   [Full Text] [Related]  

  • 10. Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice.
    Liu S; Shi D; Wang HC; Yu YZ; Xu Q; Sun ZW
    Sci Rep; 2015 Jan; 5():7771. PubMed ID: 25586780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A subcutaneous cellular implant for passive immunization against amyloid-β reduces brain amyloid and tau pathologies.
    Lathuilière A; Laversenne V; Astolfo A; Kopetzki E; Jacobsen H; Stampanoni M; Bohrmann B; Schneider BL; Aebischer P
    Brain; 2016 May; 139(Pt 5):1587-604. PubMed ID: 26956423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid beta-peptide is produced by cultured cells during normal metabolism: a reprise.
    Selkoe DJ
    J Alzheimers Dis; 2006; 9(3 Suppl):163-8. PubMed ID: 16914855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice.
    Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
    Neurosci Lett; 2016 Nov; 634():1-6. PubMed ID: 27693663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical observations with AN-1792 using TAPIR analyses.
    Hock C; Nitsch RM
    Neurodegener Dis; 2005; 2(5):273-6. PubMed ID: 16909009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease.
    Schiltz JG; Salzer U; Mohajeri MH; Franke D; Heinrich J; Pavlovic J; Wollmer MA; Nitsch RM; Moelling K
    J Mol Med (Berl); 2004 Oct; 82(10):706-14. PubMed ID: 15241501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of A beta plaque clearance following passive A beta immunization.
    Morgan D
    Neurodegener Dis; 2005; 2(5):261-6. PubMed ID: 16909007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice.
    Sigurdsson EM; Scholtzova H; Mehta PD; Frangione B; Wisniewski T
    Am J Pathol; 2001 Aug; 159(2):439-47. PubMed ID: 11485902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
    Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
    J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.